Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding Study of Amenamevir in Herpes Zoster
NCT00487682Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Nov 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Amenamevir in herpes zoster (HZ), sponsored by Astellas Pharma. Started Nov 2007; status: completed.
02
Drugs
Amenamevir
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT00487682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00487682.